Acyl-protein thioesterase 1 ( LYPLA1 ) activity promotes the growth of MDA-MB-468 triple-negative breast cancer cells
Biochemistry and Cell Biology · 01.01.2026 · 104 · 1-12
DOI: 10.1139/bcb-2025-0446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, erschienen am 01.01.2026. Verfasst von Michael Salsaa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Dalhousie University, Halifax, NS, Canada. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Lysophospholipase, Thiolester Hydrolases. Die Arbeit nennt 63 Literaturangaben. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Protein S-acylation is a lipid-based, often reversible post-translational modification that can regulate many aspects of protein behavior, including subcellular localization, protein-interactions, and activity. Emerging evidence has identified roles for individual protein acyltransferases encoded by the ZDHHC in cancers, yet the roles of de- S-acylation enzymes are less clear. Recent evidence suggests that acyl-protein thioesterase (APT1)/ LYPLA1 can impact epithelial–mesenchymal transition and metastasis. This study integrates patient datasets, CRISPR dependency data, and in vitro assays to find APT1 as a context-dependent vulnerability in triple-negative breast cancer (TNBC). Despite the highest protein abundance in luminal A MCF7 cells, basal-like MDA-MB-468 cells exhibited the most prominent specific APT1 activity, reflecting subtype-specific regulation. Inhibition of APT1 with ML348 increased S-acylation of nuclear and mitochondrial proteins without altering global acylation. Functionally, APT1 inhibition reduced cell proliferation while inducing minimal apoptosis, consistent with cytostatic growth arrest. Cell-cycle analysis revealed G1 accumulation and reduced S/G2 transition, linking proteomic changes to impaired replication. These findings establish APT1 as a regulator of TNBC proliferation through dynamic de- S-acylation of cell-cycle and mitochondrial proteins, highlighting it as a potential therapeutic vulnerability in aggressive breast cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Dalhousie University, Halifax, NS, Canada.
- Department of Biochemistry & Molecular Biology, Dalhousie University, Halifax, NS, Canada.
- Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.
- Department of Chemistry, University of Chicago, Chicago, IL, USA.
- Chan Zuckerberg Biohub, Chicago, IL 60642, USA.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Salsaa, M., Tavasoli, M., Zein, H., Pani, S., Kathayat, R., Dickinson, B., & Fairn, G. (2026). Acyl-protein thioesterase 1 ( LYPLA1 ) activity promotes the growth of MDA-MB-468 triple-negative breast cancer cells. Biochemistry and Cell Biology, 104, 1-12. https://doi.org/10.1139/bcb-2025-0446
Vancouver
Salsaa M, Tavasoli M, Zein H, Pani S, Kathayat R, Dickinson B, et al. Acyl-protein thioesterase 1 ( LYPLA1 ) activity promotes the growth of MDA-MB-468 triple-negative breast cancer cells. Biochemistry and Cell Biology. 2026;104:1-12. doi:10.1139/bcb-2025-0446
BibTeX
@article{Salsaa2026,
author = {Salsaa, Michael and Tavasoli, Mahtab and Zein, Haggag S and Pani, Shubhashree and Kathayat, Rahul S and Dickinson, Bryan C and Fairn, Gregory D},
title = {Acyl-protein thioesterase 1 ( LYPLA1 ) activity promotes the growth of MDA-MB-468 triple-negative breast cancer cells},
journal = {Biochemistry and Cell Biology},
year = {2026},
volume = {104},
pages = {1--12},
doi = {10.1139/bcb-2025-0446}
}
EUVIMED